Should liver cancer patients get surgery after drugs work? new study aims to find out
NCT ID NCT07290764
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with liver cancer that was too large or spread out to remove with surgery, but then completely disappeared after drug treatment. Researchers want to see if having surgery after the drugs work helps people live longer compared to just watching and waiting. About 729 patients will be followed for three years to compare survival rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- surgical resection
- What this could lead to
- If successful, this could show that surgery after complete remission improves long-term survival for patients with initially unresectable liver cancer.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be biased. The findings may not apply to all patients, and surgery carries its own risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuzhou University Affiliated Provincial Hospital
Fuzhou, Fujian, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can an immunotherapy drug keep liver cancer at bay after surgery?